Iodine: Deficiency and therapeutic considerations

Alternative Medicine Review

Volumn 13, Issue 2, 2008, Pages 116-127

  Patrick, Lyn ^a  

^a Southwest College of Naturopathic Medicine ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; IODINE; IODINE CASEINATE; IODINE DERIVATIVE; LUGOL; MEDROXYPROGESTERONE ACETATE; PERCHLORATE; POTASSIUM IODIDE; PROGESTERONE; SELENIUM; SODIUM IODATE; SODIUM IODIDE; SODIUM IODIDE SYMPORTER; THYROXINE;

ANTIOXIDANT ACTIVITY; AUTOIMMUNE THYROIDITIS; BRAIN DAMAGE; BREAST; BREAST CANCER; DRUG SUBSTITUTION; ENDOCRINE DISEASE; FETUS DEVELOPMENT; FIBROCYSTIC BREAST DISEASE; GOITER; HEARING LOSS; HUMAN; HYPOTHYROIDISM; IODINE DEFICIENCY; JAPAN; LACTATION; LEARNING DISORDER; MENTAL DEFICIENCY; NEUROLOGIC DISEASE; NONHUMAN; PREGNANCY; RECOMMENDED DRUG DOSE; REVIEW; UNITED STATES; UNSPECIFIED SIDE EFFECT;

ANIMALS; BREAST NEOPLASMS; DEVELOPED COUNTRIES; FIBROCYSTIC BREAST DISEASE; GOITER, ENDEMIC; HUMANS; HYPOTHYROIDISM; IODINE; JAPAN; NUTRITION POLICY; PERCHLORIC ACID; SEAWEED; THYROIDITIS, AUTOIMMUNE; UNITED STATES;

EID: 47549088263     PISSN: 10895159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (80)

1. Fuge R. Iodine deficiency: an ancient problem in a modern world. Ambio 2007;36:70-72.
2. Dunn JT. Seven deadly sins in confronting endemic iodine deficiency, and how to avoid them. J Clin Endocrinol Metab 1996;81:1332-1335.
3. Dunn JT, Delange F. Damaged reproduction: the most important consequence of iodine deficiency. J Clin Endocrinol Metab 2001;86:2360-2363.
4. DeLong GR, Leslie PW, Wang SH, et al. Effect on infant mortality of iodination of irrigation water in a severely iodine-deficient area of China. Lancet 1997;350:771-773.
5. Schaller RT Jr, Stevenson JK. Development of carcinoma of the thyroid in iodine-deficient mice. Cancer 1966;19:1063-1080.
6. Mellemgaard A, From G, Jorgensen T, et al. Cancer risk in individuals with benign thyroid disorders. Thyroid 1998;8:751-754.
7. Burgess JR, Dwyer T, McArdle K, et al. The changing incidence and spectrum of thyroid carcinoma in Tasmania (1978-1998) during a transition from iodine sufficiency to iodine deficiency. J Clin Endocrinol Metab 2000;85:1513-1517.
8. Franceschi S, Preston-Martin S, Dal Maso L, et al. A pooled analysis of case-control studies of thyroid cancer. IV. Benign thyroid diseases. Cancer Causes Control 1999;10:583-595.
9. Shakhtarin VV, Tsyb AF, Stepanenko VF, et al. Iodine deficiency, radiation dose, and the risk of thyroid cancer among children and adolescents in the Bryansk region of Russia following the Chernobyl power station accident. Int J Epidemiol 2003;32:584-591.
10. Stadel BV. Dietary iodine and risk of breast, endometrial, and ovarian cancer. Lancet 1976;1:890-891.
11. Dunn JT. What's happening to our iodine? J Clin Endocrinol Metab 1998;83:3398-3400.
12. Haddow JE, Palomaki GE, Allan WC, et al. Maternal thyroid deficiency during pregnancy and subsequent neurophysiological development of the child. N Engl J Med 1999;341:549-555.
13. Klein RZ, Sargent JD, Larsen PR, et al. Relation of severity of maternal hypothyroidism to cognitive development of offspring. J Med Screen 2001;8:18-20.
14. Marani L, Venturi S. Iodine and delayed immunity. Minerva Med 1986;77:805-809. [Article in Italian]
15. Gutekunst R. Iodine deficiency costs Germany over one billion dollars per year. IDD Newsletter 1993;9:29-31.
16. Hollowell JG, Staehling NW, Hannon WH, et al. Iodine nutrition in the Unites States. Trends and public health implications: iodine excretion data from National Health and Nutrition Examination Surveys I and III (1971-1974 and 1988-1994). J Clin Endocrinol Metab 1998;83:3401-3408.
17. Caldwell KL, Jones R, Hollowell JG. Urinary iodine concentration: United States National Health and Nutrition Examination Survey 2001-2002. Thyroid 2005;15:692-699.
18. WHO, UNICEF, and ICCIDD. Assessment of the Iodine Deficiency Disorders and Monitoring their Elimination. WHO/NHD/01.1. Geneva, Switzerland: World Health Organization; 2001:1-107.
19. Utiger RD. Maternal hypothyroidism and fetal development. N Engl J Med 1999;341:601-602.
20. Haddow JE, Palomaki GE, Allan WC, et al. Maternal thyroid deficiency during pregnancy and subsequent neurophysiological development of the child. N Engl J Med 1999;341:549-555.
21. Glinoer D. The regulation of thyroid function in pregnancy: pathways of endocrine adaptation from physiology to pathology. Endocr Rev 1997;18:404-433.
22. Bazrafshan HR, Mohammadian S, Ordookhani A, et al. An assessment of urinary and breast milk iodine concentrations in lactating mothers from Gorgan, Iran, 2003. Thyroid 2005;15:1165-1168.
23. Pearce EN, Leung AM, Blount BC, et al. Breast milk iodine and perchlorate concentrations in lactating Boston-area women. J Clin Endocrinol Metab 2007;92:1673-1677.
24. Fuse Y, Saito N, Tsuchiya T, et al. Smaller thyroid gland volume with high urinary iodine excretion in Japanese schoolchildren: normative reference values in an iodine-sufficient area and comparison with the WHO/ICCIDD reference. Thyroid 2007;17:145-155.
25. Cann SA, van Netten JP, van Netten C. Hypothesis: iodine, selenium and the development of breast cancer. Cancer Causes Controls 2000;11:121-127.
26. Nagataki S, Shizume K, Nakao K. Thyroid function in chronic excess iodide ingestion: comparison of thyroidal absolute iodine uptake and degradation of thyroxine in euthyroid Japanese subjects. J Clin Endocrinol Metab 1967:27:638-647.
27. Konno N, Taguchi H, Miura K, et al. Serum thyrotropin concentration in apparently healthy adults, in relation to urinary iodide concentration. Clin Chem 1993;39:174-175.
28. Teng W, Shan Z, Teng X, et al. Effect of iodine intake on thyroid diseases in China. N Engl J Med 2006;354:2783-2793.
29. Pisani P, Parkin DM, Bray F, Ferlay J. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 1999;83:18-29.
30. LeMarchand L, Kolonel LN, Nomura AM. Breast cancer survival among Hawaii, Japanese, and Causcasian women. Ten-year rates and survival by place of birth. Am J Epidemiol 1985;122:571-578.
31. Minami Y, Takano A, Okuno Y, et al. Trends in the incidence of female breast and cervical cancers in Miyagi Prefecture, Japan, 1959-1987. Jpn J Cancer Res 1996;87:10-17.
32. Konno N, Yuri K, Miura K, et al. Clinical evaluation of the iodide/creatinine ratio of casual urine samples as an index of daily iodide excretion in a population study. Endocr J 1993;40:163-169.
33. Spitzweg C, Harrington KJ, Pinke LA, et al. Clinical review 132: the sodium iodide symporter and its potential role in cancer therapy. J Clin Endocrinol Metab 2001;86:3327-3335.
34. Venturi S. Is there a role for iodine in breast diseases? Breast 2001;10:379-382.
35. Cocchi M, Venturi S. Iodide, antioxidant function and omega-6 and omega-3 fatty acids: a new hypothesis of biochemical cooperation? Prog Nutr 2000;2:15-19.
36. Many MC, Papadopolos C, Martin I, et al. Iodine induced cell damage in mouse hyperplastic thyroid is associated with lipid peroxidation. In: Gordon A, Gross J, Hennemann G, eds. Progress in Thyroid Research. New York, NY: Routledge; 1991:213-215.
37. Smyth PA. Role of iodine in antioxidant defence in thyroid and breast disease. Biofactors 2003;19:121-130.
38. Nolan LA, Windle RJ, Wood SA, et al. Chronic iodine deprivation attenuates stress-induced and diurnal variation in corticosterone secretion in female Wistar rats. J Neuroendocrinol 2000;12:1149-1159.
39. Thrall KD, Bull RJ. Differences in the distribution of iodine and iodide in the Sprague-Dawley rat. Fundam Appl Toxicol 1990;15:75-81.
40. Stolc V. Stimulation of iodoproteins and thyroxine formation in human leukocytes by phagocytosis. Biochem Biophys Res Commun 1971;45:159-166
41. Andersen S, Pedersen KM, Pedersen IB, Laurberg P. Variations in urinary iodine excretion and thyroid function. A 1-year study in healthy men. Eur J Endocrinol 2001;144:461-465.
42. Thompson WW, Brailey AG, Thompson B, et al. Range of effective iodine dosage in exopthalmic goiter III. Arch Int Med 1930;45:430.
43. Crohn BNE. Absorption of compound solution of iodine from the gastrointestinal tract. Arch Intern Med 1932;49:950-956.
44. Gennaro AS. Remington: The Science and Practice of Pharmacy. 19th ed. Easton, PA: Mack Pub Co.; 1995:1267.
45. Bretthauer EW. Milk transfer comparisons of different chemical forms of radioiodine. Health Phys 1972;22:257-260.
46. Topper YJ, Freeman CS. Multiple hormone interactions in the developmental biology of the mammary gland. Physiol Rev 1980;60:1049-1106.
47. Aceves C, Rodon C, Ramirez-CI, et al. Mammary 5′deiodinase (5′D) during the breeding cycle of the rat: indirect evidence that 5′D type I is specific to the alveolar epithelium. Endocrine 1995;3:95-99.
48. Goehring C, Morabia A. Epidemiology of benign breast disease, with special attention to histologic types. Epidemiol Rev 1997;19:310-327.
49. Eskin BA, Grotkowski CE, Connolly CP, Ghent WR. Different tissue responses for iodine and iodide in rat thyroid and mammary glands. Biol Trace Elem Res 1995:49:9-19.
50. Ghent WR, Eskin BA, Low DA, Hill LP. Iodine replacement in fibrocystic disease of the breast. Can J Surg 1993;36:453-460.
51. Aceves C, Anguiano B, Delgado G. Is iodine a gatekeeper of the integrity of the mammary gland? J Mammary Gland Biol Neoplasia 2005;10:189-196.
52. Kessler JH. The effect of supraphysiologic levels of iodine on patients with cyclic mastalgia. Breast J 2004;10:328-336.
53. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1997. CA Cancer J Clin 1997;47:5-27.
54. Ziegler RG, Hoover RN, Pike MC, et al. Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst 1993;85:1819-1827.
55. Smyth PP. The thyroid and breast cancer: a significant association? Ann Med 1997;29:189-191.
56. Goldman MB. Thyroid diseases and breast cancer. Epidemiol Rev 1990;12:16-28.
57. Turken O, NarIn Y, DemIrbas S, et al. Breast cancer in association with thyroid disorders. Breast Cancer Res 2003;5:R110-R113.
58. Smyth PP. Thyroid disease and breast cancer. J Endocrinol Invest 1993;16:396-401.
59. Kilbane MT, Ajjan RA, Weetman AP, et al. Tissue iodine content and serum-mediated 125I uptake-blocking activity in breast cancer. J Clin Endocrinol Metab 2000;85:1245-1250.
60. Eskin BA. Iodine and mammary cancer. Adv Exp Med Biol 1977;91:293-304.
61. Eskin BA, Parker JA, Bassett JG, George DL. Human breast uptake of radioactive iodine. Obstet Gynecol 1974;44:398-402.
62. Funahashi H, Imai T, Tanaka Y, et al. Suppressive effect of iodine on DMBA-induced breast tumor growth in the rat. J Surg Oncol 1996;61:209-213.
63. Garcia-Solis P, Alfaro Y, Anguiano B, et al. Inhibition of N-methyl-N-nitrosourea-induced mammary carcinogenesis by molecular iodine (I2) but not by iodide (I-) treatment. Evidence that I2 prevents cancer promotion. Mol Cell Endocrinol 2005;236:49-57.
64. Greer MA, Goodman G, Pleus RC, Greer SE. Health effects assessment for environmental perchlorate contamination: the dose response for inhibition of thyroidal radioiodine uptake in humans. Environ Health Perspect 2002;110:927-937.
65. Baier-Anderson C, Blount BC, Lakind JS, et al. Estimates of exposures to perchlorate from consumption of human milk, dairy milk and water, and comparison to current reference dose. J Toxicol Environ Health A 2006;69:319-330.
66. Sanchez CA, Krieger RI, Khandaker N, et al. Accumulation and perchlorate exposure potential of lettuce produced in the Lower Colorado River region. J Agric Food Chem 2005;53:5479-5486.
67. Sanchez CA, Krieger RI, Khandaker NR, et al. Potential perchlorate exposure from Citrus sp. irrigated with contaminated water. Anal Chim Acta 2006;567:33-38.
68. Snyder SA, Pleus RC, Vanderford BJ, Holady JC. Perchlorate and chlorate in dietary supplements and flavor enhancing ingredients. Anal Chim Acta 2006;567:26-32.
69. Wolff J. Perchlorate and the thyroid gland. Pharmacol Rev 1998;50:89-105.
70. Blount BC, Pirkle JL, Osterloh JD, et al. Urinary perchlorate and thyroid hormone levels in adolescent and adult men and women living in the United States. Environ Health Perspect 2006;114:1865-1871.
71. Cooper DS. Subclinical thyroid disease: consensus or conundrum? Clin Endocrinol (Oxf) 2004;60:410-412.
72. Surks MI, Ortiz E, Daniels GH, et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 2004;291:228-238.
73. Dunn JT, Semigran MJ, Delange F. The prevention and management of iodine-induced hyperthyroidism and its cardiac features. Thyroid 1998;8:101-106.
74. Burgi H, Schaffner TH, Seiler JP. The toxicology of iodate: a review of the literature. Thyroid 2001;11:449-456.
75. Robison LM, Sylvester PW, Birkenfeld P, et al. Comparison of the effects of iodine and iodide on thyroid function in humans. J Toxicol Environ Health A 1998;55:93-106.
76. Markou K, Georgopoulos N, Kyriazopoulou V, Vagenakis AG. Iodine-induced hypothyroidism. Thyroid 2001;11:501-510.
77. Stanbury JB, Ermans AE, Bourdoux P, et al. Iodine-induced hyperthyroidism: occurrence and epidemiology. Thyroid 1998;8:83-100.
78. Giray B, Hincal F, Tezic T, et al. Status of selenium and antioxidant enzymes of goitrous children is lower than healthy controls and nongoitrous children with high iodine deficiency. Biol Trace Elem Res 2001;82:35-52.
79. Derumeaux H, Valeix P, Castetbon K, et al. Association of selenium with thyroid volume and echostructure in 35- to 60-year-old French adults. Eur J Endocrinol 2003:148:309-315.
80. Zimmermann MB, Kohrle J. The impact of iron and selenium deficiencies on iodine and thyroid metabolism: biochemistry and relevance to public health. Thyroid 2002:12:867-878.